麗珠醫藥(01513.HK)注射用醋酸曲普瑞林微球獲內地註冊批准

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

麗珠醫藥(01513.HK)注射用醋酸曲普瑞林微球獲內地註冊批准

阿思達克 05-11 09:16

麗珠醫藥(01513.HK)公布，與其控股子公司上海麗珠制藥收到國家藥品監督管理局核准簽發的《藥品註冊證書》，批准注射用醋酸曲普瑞林微球藥品適用於「需要雄激素去勢治療的前列腺癌患者」。

麗珠醫藥(01513.HK)

Relevant Stocks

麗珠醫藥(01513.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

麗珠醫藥(01513.HK)注射用醋酸曲普瑞林微球獲內地註冊批准

Services

About Us

Agreement Statement